Physician profile
Brooke Albert
NPI 1932622719
$552.70
in general payments reported to CMS, 2019-2025
13 companies · $66.30 in 2025
The $66.30 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $165 · 2023: $129 · 2024: $81.30 · 2025: $66.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $94.50 | 2021 | |
| Gilead Sciences, INC. | $76.46 | 2022-2023 | Trodelvy |
| Adaptive Biotechnologies Corporation | $37.98 | 2024 | Clonoseq |
| Novartis Pharmaceuticals Corporation | $36.67 | 2024-2025 | |
| Abbvie INC. | $31.76 | 2025 | |
| Depuy Synthes Sales INC. | $23.64 | 2022 | |
| Boston Scientific Corporation | $23.52 | 2023 | |
| Merck Sharp & Dohme LLC | $22.84 | 2023 | Keytruda, Welireg, Lynparza |
| Seagen INC. | $22.52 | 2023 | Padcev |
| Mirati Therapeutics, INC. | $20.91 | 2024 | Krazati |
| Glaxosmithkline, LLC. | $20.28 | 2025 | Ojjaara |
| Biodelivery Sciences International, INC. | $16.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.